Clinical Trials Directory

Trials / Completed

CompletedNCT01242644

Comparison of a Pain Pump Versus Injectable Medication for Analgesia in Knee Arthroscopy

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
48 (actual)
Sponsor
University of South Alabama · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Hypothesis: Ropivacaine, morphine and ketorolac injected after knee arthroscopy is as effective as this solution plus ropivacaine administered intra-articularly for twenty-four hours. Three groups were assigned random patients, each group provided a different method of pain medication in order to determine the effectiveness of each treatment.

Detailed description

Arthroscopic knee patients were randomized to 1 of 3 groups. A) 30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100mL of ropivacaine (0.5%) administered at 4 mL/hour; B) an identical solution plus a pain pump containing 100-mL of normal saline administered at 4 mL/hour; C) an identical solution and no pain pump. Pain level, the amount of pain medication used and time to discharge were recorded. Clinical and radiographic evaluation was performed at nine months after surgery.

Conditions

Interventions

TypeNameDescription
DEVICEpain pump containing ropivacaine30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100mL of ropivacaine (0.5%) administered at 4 mL/hour
DEVICEsaline pain pump with injectable medication30mL of ropivacaine(0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100-mL of normal saline administered at 4 mL/hour
DRUGropivacaine, ketorolac , morphine sulfate30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected

Timeline

Start date
2006-10-01
Primary completion
2009-10-01
Completion
2010-06-01
First posted
2010-11-17
Last updated
2020-11-27
Results posted
2020-11-27

Source: ClinicalTrials.gov record NCT01242644. Inclusion in this directory is not an endorsement.